Document Detail


Maternal serum hormone concentrations for prediction of adverse outcome in threatened miscarriage.
MedLine Citation:
PMID:  17908404     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Many serum markers have been investigated in attempts to predict the outcome of pregnancy in the first trimester, with varying degrees of success. The objective of this study was to investigate whether they can be related to pregnancy outcome in women presenting with first trimester threatened miscarriage. A cohort study of women attending the Early Pregnancy Unit of a London teaching hospital was studied. A total of 122 women presenting with bleeding in the first trimester and an ongoing pregnancy, and 33 women undergoing termination of pregnancy, were recruited. The main outcome measures were gestation at delivery, birth weight and the incidence of adverse pregnancy outcome. Inhibin A, activin A, human chorionic gonadotrophin (HCG), pregnancy-associated plasma protein-A and follistatin concentrations were all significantly lower in women who subsequently miscarried when compared with live births. Serum HCG concentrations were significantly higher in cases of threatened miscarriage compared with controls (P = 0.0009). Logistic regression analysis indicated that inhibin A alone provided the best predictor for first trimester miscarriage. This pilot study suggests that placental hormone concentrations could be useful in predicting adverse pregnancy outcome in women presenting with threatened miscarriage. Inhibin A was best at predicting the likelihood of subsequent miscarriage in this group.
Authors:
J Johns; S Muttukrishna; M Lygnos; N Groome; E Jauniaux
Related Documents :
4092674 - The secretory patterns of relaxin and human chorionic gonadotropin in human pregnancy.
15663134 - Gestational trophoblastic disease: is intensive follow up essential in all women?
3348324 - Analytical versus clinical sensitivity and specificity in pregnancy testing.
3927064 - Maternal serum progesterone, 17 beta-estradiol and estriol are increased in pregnancies...
18495234 - Sperm morphology: its relevance to compensable and uncompensable traits in semen.
24468574 - Maternal exposure to bisphenol a may increase the risks of parkinson's disease through ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Reproductive biomedicine online     Volume:  15     ISSN:  1472-6483     ISO Abbreviation:  Reprod. Biomed. Online     Publication Date:  2007 Oct 
Date Detail:
Created Date:  2007-10-02     Completed Date:  2007-12-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101122473     Medline TA:  Reprod Biomed Online     Country:  England    
Other Details:
Languages:  eng     Pagination:  413-21     Citation Subset:  IM    
Affiliation:
Academic Department of Obstetrics and Gynaecology, Royal Free and University College London, UCL Campus London, 86-96 Chenies Mews, London WC1E 6HX, UK. j.johns@ucl.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortion, Threatened / blood*
Activins / blood
Adult
Biological Markers / blood
Chorionic Gonadotropin / blood
Estradiol / blood
Female
Follistatin / blood
Humans
Inhibins / blood
Pilot Projects
Placental Hormones / blood*
Pregnancy
Pregnancy Outcome
Pregnancy-Associated Plasma Protein-A / analysis
Progesterone / blood
Prospective Studies
Regression Analysis
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Chorionic Gonadotropin; 0/Follistatin; 0/Placental Hormones; 0/activin A; 0/inhibin A; 104625-48-1/Activins; 50-28-2/Estradiol; 57-83-0/Progesterone; 57285-09-3/Inhibins; EC 3.4.24.-/Pregnancy-Associated Plasma Protein-A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Management of severe early ovarian hyperstimulation syndrome by re-initiation of GnRH antagonist.
Next Document:  Patients' preferences for intrauterine insemination or in-vitro fertilization.